Fibrinogen Human Completed Phase 2 Trials for Pathological Processes in the Posterior Fossa / Dura Defects Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00681824Fibrin Sealant for the Sealing of Dura Sutures